Related news and resources
IFPMA Note for Guidance on educational and scientific events (2026 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read more
79th World Health Assembly: Constituency statement on the follow-up to the Political Declaration on non-communicable diseases
On 21 May 2026, the International Federation on Ageing delivered a joint constituency statement on the follow-up to the Political Declaration on non-communicable diseases (NCDs) at the 79th session of the World Health Assembly. We urge WHO and Member States to ensure that implementation of the Political Declaration on the prevention and control of NCDs...
Read moreGlobal biopharmaceutical leaders meet Japanese Prime Minister to reinforce action needed to retain Japan’s leadership in life‑sciences
28 MAY 2026, TOKYO – A delegation of over 20 global pharmaceutical leaders from top American, Japanese and European biopharmaceutical companies met this week with Prime Minister Sanae Takaichi to reinforce the action needed for Japan to grow its leadership in life sciences. Pharmaceutical industry amongst highest R&D intensive sectors in Japan Over the past...
Read more